The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
Open accessAbstract
Purpose: There is growing interest to enhance symptom monitoring during routine cancer care using patient-reported outcomes, but evidence of impact on clinical outcomes is limited. Methods: We randomly assigned patients receiving routine outpatient chemotherapy for advanced solid tumors at Memorial Sloan Kettering Cancer Center to report 12 common symptoms via tablet computers or to receive usual care consisting of symptom monitoring at the discretion of clinicians. Those with home computers received weekly e-mail prompts to report between visits. Treating physicians received symptom printouts at visits, and nurses received e-mail alerts when participants reported severe or worsening symptoms. The primary outcome was change in health-related quality of life (HRQL) at 6 months compared with baseline, measured by the EuroQol EQ-5D Index. Secondary endpoints included emergency room (ER) visits, hospitalizations, and survival. Results: Among 766 patients allocated, HRQL improved among more participants in the intervention group than usual care (34% v 18%) and worsened among fewer (38% v 53%; P < .001). Overall, mean HRQL declined by less in the intervention group than usual care (1.4- v 7.1-point drop; P < .001). Patients receiving intervention were less frequently admitted to the ER (34% v 41%; P = .02) or hospitalized (45% v 49%; P = .08) and remained on chemotherapy longer (mean, 8.2 v 6.3 months; P = .002). Although 75% of the intervention group was alive at 1 year, 69% with usual care survived the year (P = .05), with differences also seen in quality-adjusted survival (mean of 8.7 v. 8.0 months; P = .004). Benefits were greater for participants lacking prior computer experience. Most patients receiving intervention (63%) reported severe symptoms during the study. Nurses frequently initiated clinical actions in response to e-mail alerts. Conclusion: Clinical benefits were associated with symptom self-reporting during cancer care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“generate a real-time alert notification sent to the patient's cancer care team, based on prior research.25”
From Implementation of a remote symptom monitoring pathway in oncology care: analysis of real-world experience across 33 cancer centres in France and Belgium (2024) · cites this paper as [25]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“which have demonstrated improved symptom control, quality of life, and survival when structured symptom reporting is coupled with clinician response [3,4,7]”
From Implementing UK Oncology Nursing Society–Informed Digital Symptom Triage With Episode-Based Review in Routine NHS Acute Oncology: Service Evaluation (2026) · cites this paper as [3]
The cited source says what the claim attributes to it.
In the citing paper
“Electronic patient-reported outcome (ePRO) systems have demonstrated that symptom monitoring with clinician response improves symptom control and survival [3,4].”
From Implementing UK Oncology Nursing Society–Informed Digital Symptom Triage With Episode-Based Review in Routine NHS Acute Oncology: Service Evaluation (2026) · cites this paper as [3]
The cited source says what the claim attributes to it.
In the citing paper
“The findings of this evaluation are consistent with prior trials of ePRO monitoring”
From Implementing UK Oncology Nursing Society–Informed Digital Symptom Triage With Episode-Based Review in Routine NHS Acute Oncology: Service Evaluation (2026) · cites this paper as [3]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
EuroQol: a new facility for the measurement of health-related quality of life
(1990) · Health Policy · doi:10.1016/0168-8510(90)90421-9 · Cited by 15,736
A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk
Gray, R. J. (1988) · The Annals of Statistics · doi:10.1214/aos/1176350951 · Cited by 4,957
Velikova, G., Booth, L., Smith, A. B., Brown, P. M., Lynch, P., Brown, J. M., & Selby, P. J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.078 · Cited by 1,382
Detmar, S. B., Muller, M. J., Schornagel, J. H., Wever, L. D. V., & Aaronson, N. K. (2002) · JAMA · doi:10.1001/jama.288.23.3027 · Cited by 1,011
Kotronoulas, G., Kearney, N., Maguire, R., Harrow, A., Domenico, D. D., Croy, S., & MacGillivray, S. A. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.5948 · Cited by 953
Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer
Pickard, A. S., Neary, M. P., & Cella, D. F. (2007) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-5-70 · Cited by 932
Snyder, C., Aaronson, N., Choucair, A., Elliott, T. E., Greenhalgh, J., Halyard, M., Hess, R., Miller, D. M., Reeve, B., & Santana, M. (2012) · Quality of Life Research · doi:10.1007/s11136-011-0054-x · Cited by 808
Chen, J., Ou, L., & Hollis, S. J. (2013) · BMC Health Services Research · doi:10.1186/1472-6963-13-211 · Cited by 796
Valderas, J. M., Kotzeva, A., Espallargues, M., Guyatt, G., Ferrans, C. E., Halyard, M. Y., Revicki, D. A., Symonds, T., Parada, A., & Alonso, J. (2008) · Quality of Life Research · doi:10.1007/s11136-007-9295-0 · Cited by 775
Adverse Symptom Event Reporting by Patients vs Clinicians: Relationships With Clinical Outcomes
Basch, E., Jia, X., Heller, G., Leahy, A. B., Sit, L., Fruscione, M., Appawu, M., Iasonos, A. E., Atkinson, T. M., Goldfarb, S. B., et al. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp386 · Cited by 622
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 701–800 of 1,001
Secrest, A. M., & Chren, M. (2022) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2022.01.008 · Cited by 21
Health-Related Quality of Life (HRQoL) in Neuroendocrine Tumors: A Systematic Review
Gosain, R., Gupta, M., Roy, A. M., Strosberg, J., Glaser, K. M., & Iyer, R. V. (2022) · Cancers · doi:10.3390/cancers14061428 · Cited by 20
“Decisions informed by HRQoL can help to improve the patients’ physical and mental health and decrease the burden on health care by minimizing frequent hospital admissions and health care utilization [84].”
BackgroundGandrup, J., Selby, D., van der Veer, S. N., McBeth, J., & Dixon, W. G. (2022) · Rheumatology Advances in Practice · doi:10.1093/rap/rkac021 · Cited by 19
Coomans, M. B., Dirven, L., Aaronson, N. K., Baumert, B. G., van den Bent, M. J., Bottomley, A., Brandes, A. A., Chinot, O. L., Coens, C., Gorlia, T., et al. (2022) · Neuro-Oncology · doi:10.1093/neuonc/noac097 · Cited by 19
“33,34 When preventing or treating symptoms, this may subsequently have a positive impact on the patients’ activities in daily life and overall quality of life.”
BackgroundEkels, A., van de Poll-Franse, L. V., Posthuma, E. F. M., Kieffer, J. M., Issa, D. E., Koster, A., Nijziel, M. R., Pruijt, J. H. F. M., Stevens, W. B. C., Tick, L. W., et al. (2022) · British Journal of Haematology · doi:10.1111/bjh.18139 · Cited by 19
Xi, Z., Wei, X., Ye, Z., Wang, K., & Zhou, J. J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.921151 · Cited by 19
Dussel, V., Orellana, L., Holder, R. L., Porth, R., Avery, M. E., & Wolfe, J. (2022) · PLoS ONE · doi:10.1371/journal.pone.0277212 · Cited by 20
Gupta, S., Li, Q., Nathan, P. C., D’Agostino, N. M., Baxter, N. N., Fox, C. J., Chalifour, K., Coburn, N. G., & Sutradhar, R. (2023) · Cancer Medicine · doi:10.1002/cam4.5837 · Cited by 19
Huang, M.-Y., Weng, C.-S., Kuo, H.-L., & Su, Y. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e15798 · Cited by 19
Reinders, P., Augustin, M., Kirsten, N., Fleyder, A., & Otten, M. (2023) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.19392 · Cited by 19
“9 We identified several DHIs that are promising in achieving these goals, such an active data documentation by clients to support disease monitoring, 7 client-centred messaging to support treatment adherence 8 or applications that promote the prevention of skin cancer.”
BackgroundTang, E., Yantsis, A., Ho, M., Hussain, J., Dano, S., Aiyegbusi, O. L., Peipert, J. D., & Mucsi, I. (2023) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2023.09.007 · Cited by 21
Jacob, C., Lindeque, J. P., Müller, R., Klein, A., Metcalfe, T., Connolly, S. L., Koerber, F., Maguire, R., Denis, F., Heuss, S., et al. (2023) · npj Digital Medicine · doi:10.1038/s41746-023-00982-w · Cited by 17
“…4) whether the tool allows for data sharing and segregation for research use, 5) data fi ndability and retrievability including metadata de fi nition, 6) whether the tool is usable and accessible in the intended clinical setting, 7) affordability of the tool taking into account the local…”
Pleasurable and problematic receptive anal intercourse and diseases of the colon, rectum and anus
Dickstein, D. R., Edwards, C. R., Rowan, C. R., Avanessian, B. K., Chubak, B. M., Wheldon, C. W., Simoes, P. K., Buckstein, M. H., Keefer, L., Safer, J. D., et al. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00932-1 · Cited by 19
Mackler, E. R., Petersen, L., Severson, J. A., Blayney, D. W., Benitez, L. L., Rausch, C. R., Hough, S. M., & Griggs, J. J. (2017) · Journal of Oncology Practice · doi:10.1200/jop.2016.018390 · Cited by 19
Health-related quality of life in patients with major salivary gland carcinoma
Becker, C., Pfeiffer, J., Lange, K., & Dahlem, K. (2018) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-018-4914-7 · Cited by 19
“This potentially reduces disease-related complications and enhance patients’ experience and satisfaction [30, 31].”
BackgroundKrok‐Schoen, J. L., Fernandez, K., Unzeitig, G. W., Rubio, G., Paskett, E. D., & Post, D. M. (2018) · Supportive Care in Cancer · doi:10.1007/s00520-018-4375-y · Cited by 19
Kaur, M. N., Pusic, A. L., Sidey-Gibbons, C. J., & Klassen, A. F. (2018) · Aesthetic Surgery Journal · doi:10.1093/asj/sjy280 · Cited by 19
“collecting PROM data, (2) peer-benchmarking, (3) return on investment, and (4) concerns unique to private practice cosmetic clinics.”
BackgroundBotteman, M. F., Nickel, K., Corman, S. L., Turini, M., & Binder, G. (2019) · Supportive Care in Cancer · doi:10.1007/s00520-019-04824-y · Cited by 19
Dai, W., Xie, S., Zhang, R., Wei, X., Wu, C., Zhang, Y., Feng, W., Liao, X., Mu, Y., Zhou, H., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-030726 · Cited by 19
Brundage, M., Wu, A. W., Rivera, Y. M., & Snyder, C. F. (2020) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2020.01.022 · Cited by 19
Mending Disconnects in Cancer Care: Setting an Agenda for Research, Practice, and Policy
Alfano, C. M., Mayer, D. K., Beckjord, E. B., Ahern, D. K., Galioto, M., Sheldon, L. K., Klesges, L. M., Aronoff-Spencer, E. S., & Hesse, B. W. (2020) · JCO Clinical Cancer Informatics · doi:10.1200/cci.20.00046 · Cited by 19
Symptom Burden of Nonresected Pancreatic Adenocarcinoma
Mavros, M. N., Davis, L., Hallet, J. I., Tung, S., Mahar, A. L., Bubis, L. D., Hammad, A., Zhao, H., Earle, C. C., Barbera, L. C., et al. (2020) · Pancreas · doi:10.1097/mpa.0000000000001629 · Cited by 19
Inferences About Drug Safety in Phase III Trials in Oncology: Examples From Advanced Prostate Cancer
Drago, J. Z., Gönen, M., Thanarajasingam, G., Sacks, C. A., Morris, M. J., Kantoff, P. W., & Stopsack, K. H. (2020) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djaa134 · Cited by 19
“Patient characteristics Age, median (range), y 74 (52-97) 73 (53-92) 75 (50-92) 70 (42-92) 68 (43-90) 71 (42-93) 69 (41-89) Excellent performance status, ECOG-PS 0, % 77.”
Improving patient-reported measures in oncology: a payer call to action
Schmidt, T. A., Valuck, T., Perkins, B., Riposo, J. W., Patel, P., Westrich, K. D., Basch, E., & McClellan, M. (2020) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2020.20313 · Cited by 20
Self-citationAssessment of Multiple Co-Occurring Cancer Symptoms in the Clinical Setting
Cooley, M. E., & Siefert, M. L. (2016) · Seminars in Oncology Nursing · doi:10.1016/j.soncn.2016.08.003 · Cited by 19
Eicher, M., Ribi, K., Senn-Dubey, C., Senn, S., Ballabeni, P., & Betticher, D. C. (2018) · Psycho-Oncology · doi:10.1002/pon.4734 · Cited by 19
“There is growing evidence supporting the utility of electronic measurements for improving patient reported outcomes in cancer care.(31) While implementation (ie, time) can be challenging, our initial results from this “real‐world” study highlight opportunities for interprofessional application of potential digital sol…”
BackgroundXia, Y., Guan, X., Zhu, W., Wang, Y., Shi, Z., & He, P. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-01812-x · Cited by 19
“Therandomizationwasprimarily performedbycomputers, twostudies allocated participantsthroughpermutedblocksviacomputer 39,40 ,twostudies used computer-generated sequential numbers 30,31,46 , Billingy et al. 28,29 involved sequential transition of the participating hospitals in a randomized order,…”
InfluentialSalz, T., Schnall, R., McCabe, M. S., Oeffinger, K. C., Corcoran, S., Vickers, A. J., Salner, A., Dornelas, E. A., Raghunathan, N. J., Fortier, E., et al. (2018) · JCO Clinical Cancer Informatics · doi:10.1200/cci.17.00105 · Cited by 18
Longitudinal changes in the quality of life of oral cancer patients during the perioperative period
Aoki, T., Ota, Y., Suzuki, T., Denda, Y., Aoyama, K.-I., Akiba, T., Naito, M., & Arai, T. (2018) · International Journal of Clinical Oncology · doi:10.1007/s10147-018-1322-3 · Cited by 18
Feasibility of Tablet-Based Patient-Reported Symptom Data Collection Among Hemodialysis Patients
Flythe, J. E., Tugman, M. J., Narendra, J. H., Dorough, A., Hilbert, J., Assimon, M. M., & DeWalt, D. A. (2020) · Kidney International Reports · doi:10.1016/j.ekir.2020.04.021 · Cited by 18
Rutland, S. B., Bergquist, R. P., Hager, A., Geurs, R., Mims, C., Gutierrez, H. H., & Oates, G. R. (2020) · JMIR Formative Research · doi:10.2196/19413 · Cited by 18
“Studies have reported associations between the use of patient-generated health data and improved symptom control and quality of life [10-14], patient-clinician communication and satisfaction [15,16], reduced health care utilization, and increased survival [17-20].”
BackgroundLoh, K. P., Mohamed, M., Kadambi, S. G., Culakova, E., Xu, H., Magnuson, A. M., Flannery, M. A., Duberstein, P. R., Epstein, R. M., McHugh, C. M., et al. (2021) · The Oncologist · doi:10.1002/onco.13699 · Cited by 18
Formica, V., Nardecchia, A., Morelli, C., Lucchetti, J., Giuliano, G., Renzi, N., Gallo, C., Pellegrino, R., Massimiliani, V., Serci, C., et al. (2021) · Annals of Palliative Medicine · doi:10.21037/apm-20-2194 · Cited by 18
“Moreover, HRQoL maintenance is a fundamental requirement for innovative therapies since toxicityrelated HRQoL impairment may significantly limit their implementation, and therefore it is often set as secondary endpoint in clinical trials (9-11).”
BackgroundSella, T., Snow, C., Freeman, H., Poorvu, P. D., Rosenberg, S. M., & Partridge, A. H. (2021) · JCO Clinical Cancer Informatics · doi:10.1200/cci.21.00067 · Cited by 18
Sztankay, M. J., Wintner, L. M., Roggendorf, S., Nordhausen, T., Dirven, L., TAPHOORN, M. J. B., Leeuw, I. M. V., Velikova, G., Bottomley, A., Kuliś, D., et al. (2021) · Supportive Care in Cancer · doi:10.1007/s00520-021-06676-x · Cited by 18
The Use of Telemedicine in Cancer Clinical Trials: Connect-Patient-to-Doctor Prospective Study
Meghiref, Y., Parnot, C., Duverger, C., Difoum, F. L., Gourden, A., Yssaad, H., Leiterer, C., Bedekovic, C., Blanchard, J., Ammar, H. N., et al. (2021) · JMIR Cancer · doi:10.2196/31255 · Cited by 18
“Bash et al [16] evaluated the impact of symptom monitoring in the management of 766 cancer patients and found a significant improvement in the patients’quality of life from the monitoring (34% versus 18%, P<.”
Patient reported outcomes in the daily practice in clinical oncology: A systematic review
Lutz, A. T., Griza, A., Machado, G. M., Loose, U., Dahmer, A., & Herbert, J. S. (2022) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2022.103658 · Cited by 21
Ansari, N., Wilson, C. M., Heneghan, M. B., Supiano, K. P., & Mooney, K. H. (2022) · Supportive Care in Cancer · doi:10.1007/s00520-022-07037-y · Cited by 18
Al‐Mondhiry, J., D’Ambruoso, S. F., Pietras, C. J., Strouse, T. B., Benzeevi, D., Arevian, A. C., & Wells, K. B. (2022) · JMIR Formative Research · doi:10.2196/33849 · Cited by 18
“Specifically, the use of web-based platforms to collect patient-reported outcomes (PROs) has been associated with improvements in health-related quality of life and overall survival [8], mediated by proactive management of emergent symptoms.”
BackgroundGitonga, I., Desmond, D. M., Duda, N., & Maguire, R. (2022) · Psycho-Oncology · doi:10.1002/pon.6019 · Cited by 17
Natori, A., Sookdeo, V. D., Koru‐Sengul, T., Schlumbrecht, M. P., Calfa, C. L., Maclntyre, J., Benzo, R. M., Moreno, P. I., Crane, T. E., Garcia, S. F., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.22.01038 · Cited by 18
“2%); however, these are limited to clinical trials.(10,15) Consequently, several centers have implemented routine EHR-based PRO monitoring with ongoing efforts, including engagement from stakeholders and integration of available information technologies to expand patient outreach to any ambulatory patient across the c…”
BackgroundLiao, K. F., Wang, T., Coomber-Moore, J., Wong, D., Gomes, F., Finn, C. F., Sperrin, M., Yorke, J., & van der Veer, S. N. (2022) · BMC Cancer · doi:10.1186/s12885-022-10151-z · Cited by 20
“Randomised controlled trials comparing PROM-directed follow-up to usual care demonstrated that integrating PROMs in care pathways was associated with better symptom control, reduced emergency department attendance and hospitalisation, and improved survival [8, 9].”
Unpleasant symptoms of immunotherapy for people with lung cancer: A mixed-method study
Zhang, J., Wang, S., Zhou, Z., Cheng, L., Yu, H., Zeng, C., Xia, X., Qiao, G., & Shi, Q. (2022) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2022.104430 · Cited by 19
Laitio, A.-M., Giunti, G., & Halonen, R. (2023) · JMIR Cancer · doi:10.2196/40875 · Cited by 18
“Routine patient-reported outcome (PRO) follow-up of patients with cancer improves long-term treatment outcomes [2,3].”
BackgroundTelehealth Preferences Among Patients With Advanced Cancer in the Post COVID-19 Vaccine Era
Shih, K. K., Arechiga, A. B., Chen, X., Urbauer, D. L., de Moraes, A. R., Rodriguez, A. J., Thomas, L., Stanton, P. A., Bruera, E. D., & Hui, D. S. C. (2024) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2024.02.572 · Cited by 17
Sauer, C., Zschäbitz, S., Krauß, J., Walle, T., Haag, G. M., Jäger, D., Hiller, K., Bugaj, T. J., Friederich, H., & Maatouk, I. (2024) · Cancer · doi:10.1002/cncr.35300 · Cited by 20
“However, on closer inspection, the findings indicate some ten-dencies, such as fewer patients in the IG showing therapy ‐ related emergency visits, a conclusion consistent with the result of Basch et al. 11 Furthermore, more patients in the IG used psycho ‐ oncological support during the follow ‐ up period.”
ResultKrepper, D., Cesari, M., Hubel, N. J., Zelger, P., & Sztankay, M. J. (2024) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-024-00808-7 · Cited by 22
“Potential clinical benefits of PROs range from enhanced symptom management and patient-clinician communication to improved overall survival [4, 5].”
BackgroundZukunft jetzt − Implementierung eines IT-gestützten Distress-Screenings
Koehler, M., Hornemann, B., Holzner, B., Schäffeler, N., Zimmermann, T., Nest, A., Wifling, K., & Herschbach, P. (2017) · Der Onkologe · doi:10.1007/s00761-017-0209-7 · Cited by 19
LeBlanc, T. W., & Kamal, A. H. (2017) · The AMA Journal of Ethic · doi:10.1001/journalofethics.2017.19.5.stas1-1705 · Cited by 18
Nolte, H., Bernstein, D. I., Sussman, G. L., Fogh, B. S., Lu, S., Husøy, B., & Nelson, H. S. (2018) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2018.01.037 · Cited by 18
Patient-reported Outcomes, Functional Assessment, and Utility Values in Glaucoma
Skalicky, S. E., Lamoureux, E. L., Crabb, D. P., & Ramulu, P. Y. (2018) · Journal of Glaucoma · doi:10.1097/ijg.0000000000001155 · Cited by 18
Collado‐Borrell, R., Escudero‐Vilaplana, V., Ribed, A., Anglada-Martínez, H., Martín-Conde, M., Alonso, A. H., Codina-Jané, C., & Sanjurjo‐Sáez, M. (2019) · Journal of Oncology Pharmacy Practice · doi:10.1177/1078155219840419 · Cited by 18
“Nowadays, around 40% of deaths in the USA are caused by changes in habits and lifestyle, such as lack of adherence, thus making reduced empowerment one of the factors contributing to preventable mortality.(1,5) The mhealth may support healthcare professionals in the patients monitoring.”
BackgroundBridging the gap in outpatient care: Can a daily patient‐reported outcome measure help?
Meryk, A., Kropshofer, G., Hetzer, B., Riedl, D., Lehmann, J., Rumpold, G., Haid, A., Holzner, B., & Crazzolara, R. (2021) · Cancer Reports · doi:10.1002/cnr2.1421 · Cited by 17
Impact of a Dedicated Cancer Urgent Care Center on Acute Care Utilization
Rothberg, B. E. G., Canavan, M. E., Mun, S., Sedghi, T., Carafeno, T., Raucci, M., Dest, V., Sinanis, N., Gross, C. P., & Adelson, K. B. (2021) · JCO Oncology Practice · doi:10.1200/op.21.00183 · Cited by 19
“Presently, the most common gateway to cancer-related acute care delivery is the emergency department (ED),(6,7) a phenomenon precipitated by both the lack of same-day sick visit capacity in typical oncology practices and patients’ reluctance to communicate acute symptoms to their oncologist until they require immediat…”
BackgroundNoel, C. W., Forner, D. W. A., Chepeha, D. B., Baran, E., Chan, K., Parmar, A., Husain, Z. A., Karam, I., Hallet, J. I., Coburn, N. G., et al. (2021) · Oral Oncology · doi:10.1016/j.oraloncology.2021.105595 · Cited by 18
Coquet, J., Blayney, D. W., Brooks, J. D., & Hernandez‐Boussard, T. (2020) · Cancer Medicine · doi:10.1002/cam4.3483 · Cited by 18
Anders, C., Moorthy, P., Svensson, L., Müller, J., Heinze, O., Knaup, P., Wallwiener, M., Deutsch, T. M., Le, T.-V., & Weinert, L. (2024) · JMIR Human Factors · doi:10.2196/50926 · Cited by 17
“This more relevant treatment information, in turn, helps improve therapy monitoring, treatment quality, and patient satisfaction [8,9].”
BackgroundStuijt, D. G., van Doeveren, E. E. M., Kos, M., Eversdijk, M., Bosch, J. J., Bins, A. D., Bak, M., & van Oijen, M. G. H. (2024) · JCO Clinical Cancer Informatics · doi:10.1200/cci.24.00092 · Cited by 21
Amat-Fernández, C., Pardo, Y., Ferrer, M., Bosch, G., Lizano-Barrantes, C., Briseño, R., Vernet-Tomás, M. D. M., Fumadó, L., Beisani, M., Redondo‐Pachón, D., et al. (2025) · Health and Quality of Life Outcomes · doi:10.1186/s12955-025-02333-7 · Cited by 18
Roberts, N. A., Mudge, A., Alexander, K. E., Wyld, D., & Janda, M. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-027046 · Cited by 17
“In the co-design process, using the broader research evidence, investigated to support clinician’s recommendations, a reported symptom of grade 2 or higher for nausea, vomiting or anorexia, and grade 3 for all other symptoms is considered significant.(5) If there is an increase in symptoms greater than 2 points from t…”
Electronic symptom monitoring in patients with metastatic lung cancer: a feasibility study
Friis, R. B., Hjøllund, N. H., Mejdahl, C. T., Pappot, H., & Skúladóttir, H. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-035673 · Cited by 18
Escudero‐Vilaplana, V., Calles, A., Collado‐Borrell, R., Marzal-Alfaro, M. B., Polanco, C., Garrido, C., Suarez, J., Ortiz, A., Appierto, M., Comellas, M., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01645 · Cited by 16
“Of note, systematic weekly collection of LC associated symptoms has been related to higher survival (10–13), better HRQoL and a better allocation of health resources (12).”
BackgroundEffect of cyclooxygenase inhibitor use on immunotherapy efficacy in non‐small cell lung cancer
Kanai, O., Ito, T., Saito, Z., Yamamoto, Y., Fujita, K., Okamura, M., Hashimoto, M., Nakatani, K., Sawai, S., & Mio, T. (2021) · Thoracic Cancer · doi:10.1111/1759-7714.13845 · Cited by 17
Innominato, P. F., Komarzynski, S., Dallmann, R., Wreglesworth, N. I., Bouchahda, M., Karaboué, A., Ulusakarya, A., Subbe, C. P., Spiegel, D., & Lévi, F. (2021) · Supportive Care in Cancer · doi:10.1007/s00520-021-06262-1 · Cited by 20
“Most frequently, however, weekly electronic PRO remote monitoring has been adopted in oncological studies and practice [1, 3, 11].”
BackgroundResultInfluentialPatient-Reported Outcomes in Patients with Cardiomyopathy
Garcia, R. A., Benton, M. C., & Spertus, J. A. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01511-5 · Cited by 17
Andrews, R., Hale, G. E., John, B., & Lancastle, D. (2021) · Frontiers in Global Women s Health · doi:10.3389/fgwh.2021.757706 · Cited by 19
Kyte, D. G., Anderson, N. E., Bishop, J. R. B., Bissell, A., Brettell, E. A., Calvert, M., Chadburn, M., Cockwell, P., Dutton, M., Eddington, H., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-050610 · Cited by 17
Updates in Cancer Rehabilitation Telehealth
Chang, P. J., & Zheng, J. Y. (2022) · Current Physical Medicine and Rehabilitation Reports · doi:10.1007/s40141-022-00372-5 · Cited by 17
“Interestingly, two studies demonstrated a survival benefit with telehealth symptom monitoring [43, 44].”
BackgroundBigi, S., Borelli, E., Potenza, L., Gilioli, F., Artioli, F., Porzio, G., Luppi, M., & Bandieri, E. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1092145 · Cited by 17
Kim, Y. M., Min, A., & Hong, H. C. (2023) · Seminars in Oncology Nursing · doi:10.1016/j.soncn.2023.151406 · Cited by 16
Åsberg, R. E., Nilsen, M., Hjermstad, M. J., Reinertsen, K. V., Karlsen, J., Giskeødegård, G. F., & Reidunsdatter, R. J. (2023) · European Journal of Cancer · doi:10.1016/j.ejca.2023.112943 · Cited by 17
Lehmann, J., de Ligt, K. M., Tipelius, S., Giesinger, J. M., Sztankay, M. J., Voigt, S., van de Poll-Franse, L. V., Rumpold, G., Weger, R., Willenbacher, E., et al. (2023) · Journal of Medical Internet Research · doi:10.2196/46017 · Cited by 18
“…complements evidence from large-scale clinical trials with diverse populations that provide evidence of the benefits of PRO monitoring systems [8,14,29,32], with important nuanced information on how such a monitoring system can function in routine clinical practice for patients with multiple…”
Lopes, A. M. D. S., Colomer‐Lahiguera, S., Darnac, C., Giacomini, S., Bugeia, S., Gutknecht, G., Spurrier‐Bernard, G., Aedo-Lopez, V., Mederos, N., Latifyan, S., et al. (2023) · Supportive Care in Cancer · doi:10.1007/s00520-023-07934-w · Cited by 17
“Contrasting with other trials using PRO-CTCAETM items [44, 45], it accommodates the use of the full item library, lending itself to the heterogeneous toxicity of ICI.”
MethodPatient-Reported Outcomes in Clinical Trials: From an Endpoint to an Intervention in Cancer Care
Narra, L. R., Verdini, N. P., Lapen, K., Nipp, R. D., & Gillespie, E. F. (2023) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2023.07.002 · Cited by 19
Epstein, A. S., Knežević, A., Romano, D. R., Hoque, A., Raj, N. P., Reidy‐Lagunes, D. L., Rosa, W. E., Cruz, E. R., Calderon, C., O'Shaughnessy, S., et al. (2023) · JCO Clinical Cancer Informatics · doi:10.1200/cci.23.00125 · Cited by 17
Eng, L., Chan, R. J., Chan, A., Charalambous, A., Darling, H., Grech, L., van den Hurk, C. J. G., Kirk, D., Mitchell, S. A., Poprawski, D. M., et al. (2024) · JCO Oncology Practice · doi:10.1200/op.23.00715 · Cited by 18
Haemmerle, R. J., Paludo, J., Haddad, T. C., & Pritchett, J. C. (2024) · Current Oncology Reports · doi:10.1007/s11912-024-01534-5 · Cited by 17
“In summary, the role and scope of ePROs in the future landscape of cancer care are likely to expand as the benefits are further studied and promulgated [16, 17, 23, 24 •• , 25, 26].”
Salmani, H., Nasiri, S., & Ahmadi, M. (2024) · Digital Health · doi:10.1177/20552076241257146 · Cited by 19
“4,5 While paper-based approaches can report complications and outcomes, they face numerous limitations such as physical space constraints, data loss, and limited access for care providers to vital data when and where needed due to the accumulation of vast amounts of nonreal-time data.”
BackgroundSingh, A. P., Balogh, E. P., Carlson, R. W., Huizinga, M. M., Malin, B., Melamed, A., Meropol, N. J., Pisano, E. D., Winn, R. A., Yabroff, K. R., et al. (2024) · JCO Oncology Practice · doi:10.1200/op.24.00260 · Cited by 17
Harle, C. A., Lipori, G. P., & Hurley, R. W. (2016) · eGEMs (Generating Evidence & Methods to improve patient outcomes) · doi:10.13063/2327-9214.1240 · Cited by 17
Jiang, Q., Wang, H., Yu, L., & Gale, R. P. (2017) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-017-2353-2 · Cited by 17
Sun, V. C.-Y., Crane, T. E., Slack, S. D., Yung, A., Wright, S. R., Sentovich, S. M., Melstrom, K. A., Fakih, M., Krouse, R. S., & Thomson, C. A. (2018) · Contemporary Clinical Trials · doi:10.1016/j.cct.2018.03.010 · Cited by 17
Lucas, A. R., Bass, M., Rothrock, N. E., O'Connor, M. L., Sorkin, M., Nawyn, J., Albinali, F., & Wagner, L. I. (2018) · JMIR Medical Informatics · doi:10.2196/medinform.9525 · Cited by 18
“However, integrating such self-report systems into routine clinical care with minimal disruption is of key importance [11], which is where eHealth-based platforms may offer significant potential.”
BackgroundBrundage, M., Barbera, L. C., McCallum, F., & Howell, D. (2018) · Quality of Life Research · doi:10.1007/s11136-018-2034-x · Cited by 17
Schwartzberg, L. S., Karthaus, M., Rossi, G., Rizzi, G., Borroni, M. E., Rugo, H. S., Jordan, K., & Hansen, V. L. (2019) · Cancer Medicine · doi:10.1002/cam4.2091 · Cited by 16
Prioritizing the Patient Perspective in Oncologic Surgery
Panda, N., & Haynes, A. B. (2019) · Annals of Surgical Oncology · doi:10.1245/s10434-019-07753-6 · Cited by 17
Grove, B. E., Ivarsen, P., de Thurah, A. L., Schougaard, L. M. V., Kyte, D. G., & Hjøllund, N. H. (2019) · BMC Health Services Research · doi:10.1186/s12913-019-4461-y · Cited by 17
Li, L., Yang, B., Li, H., Yin, J., Jin, F., Han, S., Liao, N., Shi, J., Ling, R., Li, Z., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-032945 · Cited by 17
Aminnudin, A. N., Doss, J. G., Ismail, S. M., Chai, M. B., Abidin, M. Z., Basri, C. S. J. M., Kipli, N. P., & Wei, L. C. (2020) · ecancermedicalscience · doi:10.3332/ecancer.2020.1118 · Cited by 17
Using Patient-Reported Measures to Improve Outcomes in Kidney Disease
Mclaren, S., Jhamb, M., & Unruh, M. L. (2021) · Blood Purification · doi:10.1159/000515640 · Cited by 17
Taarnhøj, G. A., Lindberg, H., Johansen, C., & Pappot, H. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10091852 · Cited by 17
“The completion rate is, however, at a level observed in similar studies, even though this is an elderly and often comorbid population [12,47,48].”
BackgroundResultCurrent Challenges in Access to Melanoma Care: A Multidisciplinary Perspective
Khushalani, N. I., Truong, T., & Thompson, J. F. (2021) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_320301 · Cited by 17
Denis, F., & Krakowski, I. (2021) · Journal of Medical Internet Research · doi:10.2196/30549 · Cited by 16
“This was included in randomized studies of ePRO systems for patients with cancer [1-9].”
Patient-Reported Outcomes in Dermatology
Kirby, J. S. (2021) · JAMA Dermatology · doi:10.1001/jamadermatol.2021.1559 · Cited by 17
Enhancing Outpatient Symptom Management in Patients With Head and Neck Cancer
Noel, C. W., Du, Y. J., Baran, E., Forner, D. W. A., Husain, Z. A., Higgins, K. M., Karam, I., Chan, K., Hallet, J. I., Wright, F. C., et al. (2022) · JAMA Otolaryngology–Head & Neck Surgery · doi:10.1001/jamaoto.2021.4555 · Cited by 17
Noel, C. W., Sutradhar, R., Conn, L. G., Forner, D. W. A., Chan, W. C., Fu, R., Hallet, J. I., Coburn, N. G., & Eskander, A. E. (2022) · JAMA Otolaryngology–Head & Neck Surgery · doi:10.1001/jamaoto.2022.1629 · Cited by 18
Supportive Oncology Care at Home Intervention for Patients With Pancreatic Cancer
Nipp, R. D., Gaufberg, E., Vyas, C., Azoba, C. C., Qian, C. L., Jaggers, J. L., Weekes, C. D., Allen, J. N., Roeland, E. J., Parikh, A. R., et al. (2022) · JCO Oncology Practice · doi:10.1200/op.22.00088 · Cited by 18
“Previous work demonstrates that symptom monitoring interventions can enhance quality of life (QOL), prevent hospitalizations, and increase survival in oncology settings.(11-13) Additionally, studies have shown encouraging results for hospital-at-home interventions, mainly in general medical populations, as a strategy…”
BackgroundKaufman, H. L., Atkins, M. B., Dicker, A. P., Jim, H., Garrison, L. P., Herbst, R. S., McGivney, W. T., Silverstein, S., Wigginton, J. M., & Yu, P. P. (2017) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-017-0241-6 · Cited by 17
Novel approaches to support breast cancer survivorship care models
Gast, K. C., Allen, S. V., Ruddy, K. J., & Haddad, T. C. (2017) · The Breast · doi:10.1016/j.breast.2017.08.004 · Cited by 19
Patient Use of Electronic Methods to Self-Report Symptoms: An Integrative Literature Review
Carrasco, S., & Symes, L. (2018) · Oncology nursing forum · doi:10.1188/18.onf.399-416 · Cited by 17
Metadata
- Authors
- Basch, E., Deal, A. M., Kris, M. G., Scher, H. I., Hudis, C. A., Sabbatini, P., Rogak, L., Bennett, A. V., Dueck, A. C., Atkinson, T. M., Chou, J. F., Dulko, D., Sit, L., Barz, A., Novotny, P., Fruscione, M., Sloan, J. A., & Schrag, D.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Ethan Basch, Mark G. Kris, Howard I. Scher, Clifford A. Hudis, Paul Sabbatini, Lauren Rogak, Thomas M. Atkinson, Joanne F. Chou, Dorothy Dulko, Laura Sit, Michael Fruscione, and Deborah Schrag, Memorial Sloan Kettering Cancer Center, New York, NY; Ethan Basch, Allison M. Deal, and Antonia V. Bennett, University of North Carolina, Chapel Hill, NC; Amylou C. Dueck, Mayo Clinic, Scottsdale, AZ; Allison Barz, Children’s Hospital of Philadelphia, Philadelphia, PA; Paul Novotny and Jeff A. Sloan, Mayo Clinic,...
- ORCID
- Venue
- Journal of Clinical Oncology
- Published
- 2016-02-20
- Volume
- 34
- Issue
- 6
- Pages
- 557-565
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- PMC
- PMC4872028
- OpenAlex
- W2195040438
- Cited by
- 2,593
- References
- 36
- Citations by year
- 2026: 252 · 2025: 263 · 2024: 321 · 2023: 288 · 2022: 316 · 2021: 299 · 2020: 292 · 2019: 191 · 2018: 180 · 2017: 143 · 2016: 44
- FWCI
- 53.87
- Type
- journal article
- Language
- en
- Update notices
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Oncology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Memorial Sloan-Kettering Cancer Center
- Society of Memorial Sloan Kettering
- National Cancer Institute (P30CA008748, P30CA015083, P30CA016086)
- Topics
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Keywords
- patient-reported outcomes, symptom monitoring, cancer chemotherapy, health-related quality of life, advanced solid tumors, e-mail alerts, emergency department visits, hospitalization, survival, quality-adjusted survival, computer literacy, outpatient oncology
- MeSH terms
- Adult, Aged, Aged, 80 and over, Ambulatory Care, Antineoplastic Agents, Emergency Service, Hospital, Female, Hospitalization, Humans, Male, Middle Aged, Neoplasms, Quality of Life, Survival Rate, Internet, Nurse's Role, Electronic Mail, Self Report, Symptom Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review